Table 3.
NfL | Neurogranin | T-Tau | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Full Models | Parsimonious Models | Full Models | Parsimonious Models | Full Models | Parsimonious Models | |||||||||||||
Predictors | Coefficient | P | Partial R 2 | Coefficient | P | Partial R 2 | Coefficient | P | Partial R 2 | Coefficient | P | Partial R 2 | Coefficient | P | Partial R 2 | Coefficient | P | Partial R 2 |
| ||||||||||||||||||
(Intercept) | 4.27 | <0.001 | 4.29 | <0.001 | 196.34 | <0.001 | 212.29 | <0.001 | 192.01 | <0.001 | 181.62 | <0.001 | ||||||
Age | 0.02 | <0.001 | 0.071 | 0.02 | <0.001 | 0.12 | −0.57 | 0.018 | 0.014 | −0.76 | <0.001 | 0.040 | 0.24 | 0.049 | 0.010 | 0.36 | <0.001 | 0.033 |
Male | 0.23 | <0.001 | 0.045 | 0.23 | <0.001 | 0.043 | −14.46 | <0.001 | 0.041 | −13.60 | <0.001 | 0.038 | −0.30 | 0.862 | <0.001 | |||
Aβ42 | 0.00 | 0.107 | 0.006 | 0.02 | <0.001 | 0.064 | 0.02 | <0.001 | 0.071 | 0.02 | <0.001 | 0.14 | 0.02 | <0.001 | 0.13 | |||
PTAU | 0.02 | <0.001 | 0.071 | 0.02 | <0.001 | 0.078 | 1089.51 | <0.001 | 0.67 | 1090.84 | <0.001 | 0.67 | 1697.55 | <0.001 | 0.95 | 1696.59 | <0.001 | 0.95 |
PTAU2 | −270.01 | <0.001 | −273.84 | <0.001 | −110.86 | <0.001 | −109.15 | <0.001 | ||||||||||
PC1* | 0.05 | 0.412 | 0.002 | −5.15 | 0.162 | 0.005 | 3.03 | 0.097 | 0.007 | |||||||||
PC3† | 0.09 | 0.009 | 0.017 | 0.10 | 0.002 | 0.023 | 1.28 | 0.550 | <0.001 | 2.26 | 0.034 | 0.011 | 2.50 | 0.018 | 0.014 | |||
PC3*Male | 4.30 | 0.035 | 0.011 | |||||||||||||||
| ||||||||||||||||||
N | 408 | 408 | 408 | 408 | 408 | 408 | ||||||||||||
R2 | 0.341 | 0.336 | 0.727 | 0.726 | 0.963 | 0.963 |
PC1 is a weighted sum of WMH score and White Matter Integrity (FA-GCC) score.
PC3 is based on total number of infarcts.
Abbreviations: NfL, neurofilament light chain; t-tau, total tau. P-tau, phosphorylated tau.